If the drug's only function was appetite suppression, then both groups should have lost the same amount of weight
Glucagon is typically understood as the hormone that raises blood glucose in response to hypoglycemia, which makes its inclusion in a metabolic weight-loss compound seem counterintuitive
And so, if the Fed is forced to stop in December, yeah, you can make that argument
More recently, synthetic peptides such as glucagon-like peptide-1 (GLP-1) receptor agonists, including semaglutide, have gained popularity for treating type 2 diabetes and obesity
Can't argue with the free beer
Explore Comprehensive LabsWellness InBody Body Composition Clinical-grade body composition analysis for medical weight loss and hormone therapy monitoring